Trials / Unknown
UnknownNCT01082848
ARIpiprazole in Anorexia NErvosa
Efficacy of Aripiprazole in the Treatment of Anorexia Nervosa in Teenagers: a Pilot, Randomised, Double Blind, Placebo-controlled Clinical Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Juan A. Arnaiz · Academic / Other
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Evidence is lacking on the effects of different psychotropic drugs in the treatment of anorexia nervosa (AR). However, HVA levels seem to be elevated in this disease, therefore suggesting a role for drugs with a partial agonist profile on dopaminergic receptors. This is a pilot study assessing the effects of aripiprazole in teenagers with AR, compared with a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aripiprazole | 10 mg QD during 26 weeks |
| DRUG | placebo | QD during 26 weeks |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2010-03-09
- Last updated
- 2013-02-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01082848. Inclusion in this directory is not an endorsement.